IPCA-Amitriptyline

País: Nueva Zelanda

Idioma: inglés

Fuente: Medsafe (Medicines Safety Authority)

Ingredientes activos:

Amitriptyline hydrochloride 50mg;  ;  ;  ; Amitriptyline hydrochloride 50mg

Disponible desde:

Ipca Pharma (NZ) Pty Limited

Designación común internacional (DCI):

Amitriptyline hydrochloride 50 mg

Dosis:

50 mg

formulario farmacéutico:

Film coated tablet

Composición:

Active: Amitriptyline hydrochloride 50mg       Excipient: Colloidal silicon dioxide Crospovidone Hypromellose Iron oxide red Lactose monohydrate Macrogol 6000 Magnesium stearate Maize starch Microcrystalline cellulose Purified talc   Quinoline yellow Titanium dioxide Active: Amitriptyline hydrochloride 50mg Excipient: Colloidal silicon dioxide Crospovidone Hypromellose Indigo carmine aluminium lake Lactose monohydrate Macrogol 6000 Magnesium stearate Maize starch Microcrystalline cellulose Purified talc   Sunset yellow FCF Titanium dioxide

Unidades en paquete:

Blister pack, PVC/Aluminium, 10 tablets

clase:

Prescription

tipo de receta:

Prescription

Fabricado por:

Vasudha Pharma Chem Limited

indicaciones terapéuticas:

For the treatment of depression.

Resumen del producto:

Package - Contents - Shelf Life: Blister pack, PVC/Aluminium - 10 tablets - 36 months from date of manufacture stored at or below 25°C protect from light and moisture - Blister pack, PVC/Aluminium - 30 tablets - 36 months from date of manufacture stored at or below 25°C protect from light and moisture - Blister pack, PVC/Aluminium - 50 tablets - 36 months from date of manufacture stored at or below 25°C protect from light and moisture - Blister pack, PVC/Aluminium - 100 tablets - 36 months from date of manufacture stored at or below 25°C protect from light and moisture

Fecha de autorización:

2011-09-27